Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Red Light ALA PDT Well Tolerated in AK Treatment

Photomed Laser Surg; ePub 2017 Dec 11; Paragh, et al

Red light 5-aminolevulinic acid (ALA) photodynamic therapy (PDT) of actinic keratosis (AKs) is very well tolerated with the 2-step irradiance protocol, according to a recent study. Researchers performed a retrospective chart review to assess the level of pain during AK treatment by red light PDT (n=99). Natural density filter was used to reduce the irradiance of the light source and initially 10 J/cm2 dose was delivered at 35 mW/cm2 and then, 65 J/cm2 dose was delivered at 70 mW/cm2. Pain level was measured using a 10-point visual analog scale at 3 points during the procedure. They found:

  • Pain was low to moderate in most patients (mean ± standard error of the mean pain score: 2.35 ± 0.19).
  • Higher pain was seen mid-procedure vs at the beginning and at the end of PDT.
  • There was no significant difference in pain perception between genders and different treatment areas.

Citation:

Paragh G, Zeitouni NC. Two-step irradiance treatment can achieve excellent pain control during red light 5-aminolevulinic acid photodynamic therapy for actinic keratosis. [Published online ahead of print December 11, 2017]. Photomed Laser Surg. doi:10.1089/pho.2017.4351.

This Week's Must Reads

ALT-70 Gets High Marks for Diagnosing Cellulitis, J Am Acad Dermatol; ePub 2018 Jul 9; Li, et al

MMS/MART-1 Immunostaining for Atypical Melanocytes, J Am Acad Dermatol; ePub 2018 Jul 9; Etzkorn, et al

Economic Analysis of Noninvasive Pathologic Assay, JAMA Dermatology; ePub 2018 Jul 11; Hornberger, et al

Use of Advanced Practice Professionals on the Rise, JAMA Dermatology; ePub 2018 Jul 11; Zhang, et al

Folate and Risk of Cutaneous Melanoma in Women, Cancer Epidemiol; 2018 Aug; Dhana, Ten, Li, et al

Must Reads in Actinic Keratosis

Red Light ALA PDT Well Tolerated in AK Treatment, Photomed Laser Surg; ePub 2017 Dec 11; Paragh, et al

Cost of Managing AK Varies by Region, JAMA Dermatol; ePub 2017 Mar 1; Kirby, et al

Physician Wording Role in Seeking AK Treatment, JAMA Dermatol; ePub 2017 Jan 18; Berry, Butt, et al

Acantholysis in SCC Not Considered High Risk, J Am Acad Dermatol; ePub 2016 Nov 23; Ogawa, et al

Prevalence of Nonmelanoma Skin Cancers High in VHA, Dermatol Surg; ePub 2016 Jul 25; Yoon, Phibbs, et al